Top Abstract Purchase Related
Home
>
Node
>
Subnode

Protein C and plasma serine protease inhibitors in patients with essential hypertension

Kłoczko, J.; Bielawiec, M.; Galar, M.; Czaczkowska, T.; Wojtukiewicz, M.

Polski Tygodnik Lekarski 46(50-52): 974-976

1991

ISSN/ISBN: 0032-3756
PMID: 1669185
Document Number: 384338
Plasma protein C and serine protease inhibitors together with some other hemostasis parameters have been determined in 60 patients with essential hypertension. Significant decrease in protein C and alpha 2-antiplasmin levels, increased fibrinogen, fibrinopeptide A, WF: Ag, plasminogen, and prolongation of euglobulin fibrinolysis time have been observed. Results indicate hypercoagulability and fibrinolysis defect in hypertensive patients.

Document emailed within 1 workday
Secure & encrypted payments

Swiatkowski, M.; Pulkowski, G.; Kłopocka, M.; Budzyński, J.; Wiśniewsk, E.; Kotschy, M. 2001: Serine protease inhibitors in plasma of patients with ulcerative colitis Przeglad Lekarski 58(2): 67-70
Piatkowska, M.; Kotschy, M.; Rość, D.; Wiśniewska, E.; Opoka, J. 1994: Plasma serine protease inhibitors in patients with liver cirrhosis Acta Haematologica Polonica 25(2): 145-149
Hilgeroth, A.; Langner, A. 2000: Plasma protein binding properties of dimeric 4-aryl-1,4-dihydropyridines as novel non peptidic HIV-1 protease inhibitors Die Pharmazie 55(7): 542-543
Liu, J.; Wang, H.-Y.; Li, J.-Y. 2008: Advances in researches on epididymal WFDC-type serine protease inhibitors Zhonghua Nan Ke Xue 14(11): 1027-1030
Hudig, D.; Allison, N.J.; Pickett, T.M.; Winkler, U.; Kam, C.M.; Powers, J.C. 1991: The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors Journal of Immunology 147(4): 1360-1368
Hashimoto, E.; Takeuchi, F.; Yamamura, H. 1990: Protease-activated form of protein kinase C with Mr 80,000 generated from rat liver plasma membrane by trypsin-like protease Biochemistry International 21(5): 949-957
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Takayama, Y.; Takada, F.; Takahashi, A.; Kawakami, M. 1994: A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s Journal of Immunology 152(5): 2308-2316
Schmid, J.; Weissmann, C. 1987: Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes Journal of Immunology 139(1): 250-256
Derkx, F.H.; Bouma, B.N.; Schalekamp, M.A. 1984: Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors Journal of Laboratory and Clinical Medicine 103(4): 560-573
Tomov, I.; Elenkova, A. 1986: Plasma volume changes in essential hypertension patients Vutreshni Bolesti 25(3): 108-112
Sakai, J. 2001: Site-1 protease: a subtilisin-like serine protease that cleaves SREBPs for controlling the lipid biosynthesis in animal cell Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 2): 277-282
Ku, G.S.; Quigley, J.P.; Sultzer, B.M. 1983: The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme Journal of Immunology 131(5): 2494-2499
Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Feng, T.; Yuan, H. 2001: Cytomegalovirus infection associated with plasma endothelin and P-selectin in patients with essential hypertension Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(4): 377-379
Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K. 1984: Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(6): 779-789
Kravtsov, G.M.; Dulin, N.O.; Postnov, I.V. 1988: Protein kinase a and C activity of erythrocytes in patients with essential hypertension Kardiologiia 28(5): 96-98
Ghosh, P. 1989: The role of serine proteinases and serine proteinase inhibitors in the pathobiology of connective tissues Nihon Seikeigeka Gakkai Zasshi 63(5): 643-652
Bhatia, J.; Mahajan, P.; Sikka, M.; Kalra, O.P. 2001: Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension Indian Journal of Medical Sciences 55(9): 491-494